Breath Biopsy Conference 2020
View the content from the 2020 Breath Biopsy Conference
Joachim Pleil at the 2020 Breath Biopsy Conference
KEYNOTE (45 min) - Exhaled breath aerosols: Thoughts on sampling, analysis and safety in the era of COVID-19
ViewRenelle Myers at the 2020 Breath Biopsy Conference
KEYNOTE (40 min) - Breath biomarkers for the early detection of lung cancer
ViewTerence Risby at the 2020 Breath Biopsy Conference
KEYNOTE (45 min) - Lipid peroxidation, a measure of human homeostasis
ViewMarc van der Schee at the 2020 Breath Biopsy Conference
COVID-19 session (30 min) - Breath Biopsy detection of SARS-CoV-2 in aerosols: technical and clinical validation
ViewJulia Greenwood at the 2020 Breath Biopsy Conference
Study Design session (25min) - Enhancing Breath Biopsy through TD-GC-Orbitrap mass spectrometry: OMNI assay (Talk sponsored by Thermo Fisher Scientific)
ViewGiuseppe Ferrandino at the 2020 Breath Biopsy Conference
Liver Disease session (25 min) - Breath Biopsy to discover novel exogenous volatile organic compounds (EVOCs) biomarkers for chronic liver disease
ViewBen Henderson at the 2020 Breath Biopsy Conference
Early Career presentation (25min) - The peppermint breath test benchmark for PTR-MS
ViewMaria Akiki at the 2020 Breath Biopsy Conference
Early Career presentation (20 min) - Detection of VOC biomarkers specific to chronic kidney disease by analysis of exhaled air from dialysis patients at advanced stages
ViewPanel Discussion at the 2020 Breath Biopsy Conference
Discussion (1 hour) - Why is it important for breath research to understand the biological origins of VOCs?
ViewPierre-Hugues Stefanuto at the 2020 Breath Biopsy Conference
Study Design session (25min) - Translating breath-based asthma phenotyping into clinical practice
ViewRoy Goodacre at the 2020 Breath Biopsy Conference
Study Design session (35 min) - Metabolomics by numbers: Lessons from large-scale phenotyping
ViewScott Friedman at the 2020 Breath Biopsy Conference
Liver Disease session (25 min) - Diagnostic challenges in non-alcoholic fatty liver disease (NAFLD)
ViewLaura McGregor at the 2020 Breath Biopsy Conference
Study Design session (15 min) - Novel strategies for biomarker discovery using untargeted GC-MS and chemometrics (Talk sponsored by Markes International and SepSolve)
ViewJohn Plevris at the 2020 Breath Biopsy Conference
Liver Disease session (35 min) - Volatomic analysis has the potential to non invasively and accurately stratify patients with non alcoholic fatty liver disease
ViewPaul Thomas at the 2020 Breath Biopsy Conference
COVID-19 session (25 min) - A feasibility study of COVID-19 detection in participant with respiratory symptoms
ViewJames Logan at the 2020 Breath Biopsy Conference
COVID-19 session (35 min) - Using trained dogs to detect the odour of COVID-19 infection
ViewAnthony Hobson at the 2020 Breath Biopsy Conference
VOC Applications session (30 min) - Digestion, fermentation and function – Using breath analysis to assess digestive health
ViewJames Covington at the 2020 Breath Biopsy Conference
VOC Applications session (30 min) - The diagnosis and monitoring of inflammatory bowel disease by the analysis of breath and other human waste
ViewAgi Smolinska at the 2020 Breath Biopsy Conference
VOC Applications session (30 min) - Exhaled breath as early predictive signatures of asthma in children
ViewStephen Fowler at the 2020 Breath Biopsy Conference
VOC Applications session (25 min) - Breath analysis - not (only) for diagnosis
ViewAlan Griffiths at the 2020 Breath Biopsy Conference
VOC Applications session (15 min) - The timeline of breath analysis - a brief history of when, why and how (Talk sponsored by LECO)
View